Similar articles

• Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

  Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators. Hohnloser SH, et al. N Engl J Med. 2004 Dec 9;351(24):2481-8. doi: 10.1056/NEJMoa041489. N Engl J Med. 2004. PMID: 15590950 Clinical Trial.
• Implantable cardioverter-defibrillators after myocardial infarction.

  Myerburg RJ. Myerburg RJ. N Engl J Med. 2008 Nov 20;359(21):2245-53. doi: 10.1056/NEJMra0803409. N Engl J Med. 2008. PMID: 19020326 Review. No abstract available.
• Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.

  Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I; Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Choy B, et al. Am J Cardiol. 2010 Mar 1;105(5):581-6. doi: 10.1016/j.amjcard.2009.10.041. Epub 2010 Jan 22. Am J Cardiol. 2010. PMID: 20185000 Clinical Trial.
• Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

  Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Roes SD, et al. Circ Cardiovasc Imaging. 2009 May;2(3):183-90. doi: 10.1161/CIRCIMAGING.108.826529. Epub 2009 Mar 23. Circ Cardiovasc Imaging. 2009. PMID: 19808591
• [ICD-implantation--for which patients is its value for primary prevention secure?].

  Fiek M, Reithmann C, Steinbeck G. Fiek M, et al. Dtsch Med Wochenschr. 2006 Sep 29;131(39):2165-8. doi: 10.1055/s-2006-951348. Dtsch Med Wochenschr. 2006. PMID: 16991035 Review. German. No abstract available.